| Objective:To observe the clinical effect of "xuanyang tiaoqi method" acupuncture combined with wheat moxibustion on subthreshold depressionMethods: 60 patients with subthreshold depression who met the inclusion criteria were divided into treatment group and control group according to the random number table,with 30 cases in each group.The treatment group was treated with acupuncture combined with wheat moxibustion,while the control group was treated with conventional acupuncture.Treatment group: acupuncture point selection: Bai Hui,Yin Tang,Dan Zhong,He Gu,Tai Chong.Acupuncture method: Direct acupuncture or plain acupuncture for 10-20 mm at acupoints,small amplitude lifting thrusting till gas has got,using reinforcing and reducing method,for 30 min,every 10 mins hand-manipulating the needle once.Wheat moxibustion points:Da Zhui,Zhi Yang,Ming Men,Zhong Wan,Xia Wan,Qi Hai,Guan Yuan,eachpoint 3 wheat moxibustion.Operation:Apply a little paraffin oil to the moxibustion point,place the moxa cone with a diameter of about 0.5cm and a height of about 0.5cm on the skin of the acupuncture point and ignite the moxibustion.When the moxa cones burns until the patient feels a slight burning sensation,remove the pillar of moxa,3 moax cones of moxibustion every time for the treatment.Control group: Conventional mile-needle acupuncturetreatment was used only,main points were taken: Shen Men,Da Ling,Nei Guan,Qi Men,Xin Shu,He Gu,Tai Chong,plus or minus points:Xing Jian Gan Shu Nei Ting Zhi Gou.The acupuncture operation of the control group was the same as that of the treatment group.Patients in both groups were treated three times a week,with a treatment interval of more than 24 h.The treatment lasted for 1 week and 4 consecutive treatment courses.Two groups of patients were evaluated by TCM Syndrome scale 、 The depression scale(CES-D)、 17 Hamilton Depression scale(HAMD-17)and quality of life scale(SF-12)before and 4 weeks after treatment.The statistical software SPSS17.0 was used for statistical analysis.Results:1.There were no statistically significant differences in gender,age,course of disease,TCM Syndrome、CES-D、HAMD-17 and SF-12 scores between the two groups before treatment(P>0.05),suggesting that the two groups of base-lines are balanced and comparable.2.Comparison of clinical efficacy:The clinical efficacy of the treatment group was better than that of the control group(P<0.05).3.Comparison of TCM syndrome scores: The score of patients in the two groups after treatment significantly decreased compared with that before treatment,the difference was statistically significant(P<0.05).After treatment,the score of the treatment group decreased significantly compared with the control group(P<0.05).4.Comparison of CES-D scores:The scores of patients in the two groups decreased significantly after treatment compared with before treatment(P<0.05);After treatment,the score of the treatment group decreased significantly compared with that of the control group(P<0.05).5.Comparison of HAMD-17 scores: The score of patients in the two groups after treatment significantly decreased compared with that before treatment(P< 0.05).After treatment,the score of the treatment group decreased significantly compared with the control group(P< 0.05).6.Comparison of SF-12 scores:After treatment,there were significant differences between the two groups in somatic role function,body pain,general assessment of health status,vitality,social function,emotional function,psychological function,and somatic activity function(P<0.05);After treatment,the improvement of physical role function,body pain,overall health status,vitality,social function,emotional function,psychological function and other aspects of the treatment group was significantly better than the control group(P<0.05).But,there was no significant difference in body activity between the groups(P>0.05).Conclusion: “Xuanyang Tiaoqi regulating” acupuncture combined with wheat moxibustion treatment can reduce the self-rated depressive symptoms and the frequency of occurrence,effectively improve the depressive symptoms of patients by other with subthreshold depression,and improve the quality of life of patients,which is worthy of clinical promotion. |